Latest Articles

  • What are the management considerations for venous thromboembolic events in patients with cirrhosis?
    Marie M. Plante, MD, BSN, RN, Emily B. Wolf, MD and Razvan M. Chirila, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 86-88; DOI: https://doi.org/10.3949/ccjm.91a.23045

    The authors review the current evidence on venous thromboembolic event (VTE) risk prediction in patients with cirrhosis, as well as VTE prophylaxis and anticoagulant therapy.

  • In Reply: Surgical and procedural management of benign prostatic hyperplasia
    Ayodeji E. Sotimehin, MD and Bradley C. Gill, MD, MS
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 83-84; DOI: https://doi.org/10.3949/ccjm.91c.02004
  • Surgical and procedural management of benign prostatic hyperplasia
    Sameer Gadani, MD, Ihab Haddadin, MD, Justin Guan, MD, Michael Bergen, MD and Abraham Levitin, MD
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 83; DOI: https://doi.org/10.3949/ccjm.91c.02003
  • Management of venous thromboembolism in patients with active cancer
    Heloni M. Dave, MBBS and Alok A. Khorana, MD, FACP, FASCO
    Cleveland Clinic Journal of Medicine February 2024, 91 (2) 109-117; DOI: https://doi.org/10.3949/ccjm.91a.23017

    The authors review the presentation and diagnosis of venous thromboembolism in patients with cancer and present an approach to treatment that aims to balance the bleeding risk from anticoagulation with the risk of recurrent thrombosis.

  • It’s a new year, looking back and looking forward
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 15-16; DOI: https://doi.org/10.3949/ccjm.91b.01024

    Reflections on highlights from 2023 and impending changes in 2024, along with some acknowledgments and farewells.

  • Wearable cardiac monitors: Where do we stand?
    Jakub Sroubek, MD, PhD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 31-32; DOI: https://doi.org/10.3949/ccjm.91a.23081

    Wearable monitors perform well as screening tools for atrial fibrillation, but questions remain: Can they help with stroke prevention, what is their role in patients with known atrial fibrillation, and how do we streamline interpretation?

  • Late complications after allogeneic hematopoietic cell transplant
    Pelin Batur, MD, FACP, MSCP
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 19; DOI: https://doi.org/10.3949/ccjm.91c.01001
  • Consumer-grade wearable cardiac monitors: What they do well, and what needs work
    Consumer-grade wearable cardiac monitors: What they do well, and what needs work
    Abdilahi Mohamoud, MBBS, Joseph Jensen, MD and Kevin G. Buda, DO
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 23-29; DOI: https://doi.org/10.3949/ccjm.91a.23030

    The authors review common consumer-grade wearables, including the accuracy of these monitors compared with medical-grade devices, and present an approach to managing rate or rhythm abnormalities identified on at-home monitoring.

  • When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

    Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

  • 2023 Update in ambulatory general internal medicine
    Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

    Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

Pages